Literature DB >> 6346913

Use of physiologic monitoring to predict outcome and to assist in clinical decisions in critically ill postoperative patients.

W C Shoemaker, P Appel, R Bland.   

Abstract

A predictive index based on cardiorespiratory-monitored values of an earlier series of postoperative critically ill patients was tested in prospective clinical trials and found to be reasonably accurate, sensitive, and specific. The hypothesis was tested that the median values of patients who survived life-threatening postoperative conditions, rather than the norms of unstressed, healthy volunteer subjects, constitute a first approximation to the optimal therapeutic goals for critically ill postoperative patients. In a prospective series of 223 consecutive, critically ill postoperative patients, normal values were used as the therapeutic goals of the control patients, whereas the median values of surviving patients were used as the goals of therapy for the protocol group. The clinical conditions of the protocol group were at least as severe as those of the control group, but the mortality was significantly less in the protocol group (12.5 percent) than in the control group (35 percent); the number of life-threatening complications were also greater in the control group. These data suggest that at least half and possibly as much as two thirds of postoperative deaths may be due to physiologic problems that can be identified, described, predicted, and prevented. Therapy for the critically ill patient should be defined by physiologic criteria, and administration of therapy should be monitored to attain prophylactically optimal physiologic goals rather than giving therapy after a deficiency has occurred to attain normal values.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346913     DOI: 10.1016/0002-9610(83)90257-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  26 in total

1.  Designing an outcome-oriented computer decision-support system for cardiovascular ICU--a preliminary report.

Authors:  F Lau; D Vincent; D Fenna; R Goebel; D Modry
Journal:  J Med Syst       Date:  1991-12       Impact factor: 4.460

2.  Water distribution and oxygen delivery.

Authors:  W C Shoemaker
Journal:  West J Med       Date:  1985-08

3.  National survey of fluid therapy in acute pancreatitis: current practice lacks a sound evidence base.

Authors:  Matthew D Haydock; Anubhav Mittal; Marc van den Heever; Jeremy I Rossaak; Saxon Connor; Michael Rodgers; Maxim S Petrov; John A Windsor
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

4.  Our study 20 years on: a randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients.

Authors:  Owen Boyd; R Michael Grounds
Journal:  Intensive Care Med       Date:  2013-10-01       Impact factor: 17.440

Review 5.  New tools for optimizing fluid resuscitation in acute pancreatitis.

Authors:  Perrine Bortolotti; Fabienne Saulnier; Delphine Colling; Alban Redheuil; Sebastien Preau
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 6.  Cost-effective use of the surgical intensive care unit.

Authors:  S D Eyer; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

7.  Goal-Directed Fluid Therapy: What the Mind Does Not Know, the Eye Cannot See.

Authors:  Joshua A Bloomstone; Randal O Dull; Lais H C Navarro
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

8.  Relation of oxygen transport patterns to the pathophysiology and therapy of shock states.

Authors:  W C Shoemaker
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 9.  Clinical review: Goal-directed therapy in high risk surgical patients.

Authors:  Nicholas Lees; Mark Hamilton; Andrew Rhodes
Journal:  Crit Care       Date:  2009-10-26       Impact factor: 9.097

Review 10.  Monitoring trauma and intensive care unit resuscitation with tissue hemoglobin oxygen saturation.

Authors:  Rachel J Santora; Frederick A Moore
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.